Maturation, pharmacogenomics and metabolomics as factors determining pharmacokinetic and pharmacodynamics profile of alpha-agonist in pediatric intensive care unit patients. JMS [Internet]. 2016 Sep. 28 [cited 2025 Dec. 5];85(3):219-22. Available from: https://jms.ump.edu.pl/index.php/JMS/article/view/147